Zobrazeno 1 - 10
of 77
pro vyhledávání: '"M. E. Briquel"'
Publikováno v:
Annales de biologie clinique. 69:713-719
Taking in charge the delivery of pregnant women with inherited major deficiency of factor VII (FVII) is poorly reported in literature. We report here the haemorrhagic prophylaxis of delivery by recombinant activated FVII (rFVIIa) in a 27-year-old wom
Autor:
Jean-Louis Lorenzini, Marie Anne Bertrand, Marie-Christine Woronoff-Lemsi, Patricia Pouzol, E. Tissot, Virginie Nerich, K. Demesmay, M. E. Briquel, Albert Faradji
Publikováno v:
Pharmacy World & Science. 30:287-292
Objective The aim of this study was to assess the consumption of anti-haemophilic drugs by adults and children with severe haemophilia A or B (residual activity of FVIII or FIX ≤2%) and to quantify the average direct medical costs. Method A retrosp
Autor:
M.-A. Bertrand, M. E. Briquel, Marc Trossaert, A. Doncarli, O. Pincemaille, Hervé Chambost, Thierry Calvez
Publikováno v:
Haemophilia. 13:712-721
Summary. In the early nineties, the occurrence of hepatitis A outbreaks in some patients with haemophilia in some countries led French health authorities to recommend hepatitis A virus (HAV) vaccination in HAV-seronegative haemophiliacs. The French
Publikováno v:
Annales d'Otolaryngologie et de Chirurgie Cervico-faciale. 124:222-227
Resume Introduction La maladie de Willebrand peut etre diagnostiquee tardivement a l'occasion d'une intervention chirurgicale. Les recommandations francaises ne preconisent pas la realisation d'examens preoperatoires en l'absence d'antecedent personn
Autor:
J. Goudemand, A. Parquet, R. d�Oiron, N. Stieltjes, C. Gu�rois, J. Fonlupt, M. Alcalay, C. N�grier, J. P. Cazenave, M. E. Briquel, E. Fressinaud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::59cd7ed4f84aa3ffa7d2cba8b5ec70de
https://doi.org/10.1159/000423820
https://doi.org/10.1159/000423820
Publikováno v:
Haemophilia. 18:e383-e385
Autor:
Guillaume Mourey, L. S. Aho, E de Maistre, B. Frotscher, Marc Trossaert, Nathalie Hezard, Catherine Ternisien, L. Dumont, Philippe Nguyen, M. E. Briquel, F. Volot, B. Tardy, David Vandroux, M.-A. Bertrand
Publikováno v:
Thrombosis and haemostasis. 112(4)
SummaryThe ristocetin cofactor activity assay (VWF:RCo) is the reference method for assessing von Willebrand factor (VWF) activity but remains difficult to perform, and the coefficient of variation of the method is high (about 20–30%). This study e
Autor:
Ghislaine Cherel, M. E. Briquel, Koen Mertens, Peter J. Lenting, Dominique Meyer, Mariëtte Boon-Spijker, Jenny Goudemand, Ria C. Boertjes, Arja de Goede-Bolder, Olivier D. Christophe, Roseline d'Oiron, Solange Gaillard, Jean-Maurice Lavergne
Publikováno v:
Blood, 98(5), 1416-1423. American Society of Hematology
Development of inhibitory antibodies is a serious complication of treatment with repeated factor IX infusions in a minority of patients with hemophilia B. Such antibodies detected in 8 patients have been characterized. Typing studies revealed that pa
Publikováno v:
Journal of Clinical Laboratory Analysis. 10:6-12
The implication of autoantibodies with anticoagulant and/or so-called antiphospholipid activities, under clinical circumstances with vascular obliteration, has led to the development of various types of tests allowing their detection. The most used t
Autor:
Edith Fressinaud, M. E. Briquel, M. Alcalay, N. Stieltjes, J. Fonlupt, J.P. Cazenave, C. Guerois, Claude Negrier, A. Parquet, Roseline d'Oiron, J. Goudemand
Publikováno v:
Vox Sanguinis. 67:9-13
The prevalence of serum antibodies to hepatitis A virus (HAV) in 793 hemophilia A (HA) and 89 hemophilia B (HB) patients coming from 10 French Hemophilia Centers and treated since 1986-1987 with solvent/detergent (SD)-treated products is reported. Th